Full-Time

Product Director: Phorums

Confirmed live in the last 24 hours

BioPhorum

BioPhorum

51-200 employees

Collaborative platform for biopharmaceutical innovation

No salary listed

Senior, Expert

Birmingham, UK

Home-based role within the United Kingdom; ad hoc international travel required for events.

Category
Product Management
Product
Required Skills
Agile
Product Management
Data Analysis
Requirements
  • Strong and proven experience in product or category management, within a membership, services or ‘people’ business, can articulate the nuances specific to these markets including the strategic product requirements and how to deliver against these requirements operationally
  • Highly commercial and numerate, able to build commercial models and conduct the required analyses to make informed data driven product decision especially regarding the viability of potential products / services
  • Can operate in an agile format, build prototypes, iterate, and update based on market and member/customer feedback
  • Experienced working within a private equity environment, ability to operate at pace, understand the importance of impact and driving outcomes for customers
  • Practical experience within the Bio-manufacturing, Pharmaceutical or life-sciences industries can translate industry nuances or situations into practical outcomes for BioPhorum and the Phorum organisation
  • Highly organised, able to develop strong go-to-market and project plans and execute against them
  • Strong collaboration skills — able to bring together a collection of ideas and concepts, make the best recommendations based on those inputs and able to hold-the-course to ensure those recommendations are brough to life
  • Can think strategically, while acting pragmatically isn’t afraid of rolling up sleeves to ‘get the job done’ to a very high standard; has a strong bias to action — enjoys the ‘thrill’ of delivery and driving impact across a business
  • Very verbal and written strong communication skills, able to influence a variety of personalities and personas
  • Excellent presentation skills, able to build and present compelling stories, take people ‘on a journey’
  • Creative thinker or “corkscrew thinker” who can demonstrate strong problem solving skills, can ideate solutions to problems quickly, able to express these ideas in clear digestible terms, turning ideas and solution into reality
  • Ambitious on behalf of their portfolio – pro-actively builds propositions, assesses new opportunities and acts at pace to make quick decisions
Responsibilities
  • Define and deliver a product strategy for the Phorum business that identifies how to protect and grow membership revenues and margins from established Phorums, new and emerging Phorums, and future Phorums — continually finding new ways and means of collaborating
  • Provide strategic inputs to support the creation and update of the Phorum organisation strategy, ensuring the Group Phorum Director has the necessary market and product data and feedback (e.g., NPS), themes, and trends to define a clear and actionable strategy, both annually and longer term
  • In collaboration with the Phorum leadership team, own the upkeep and maintenance of the BioPhorum membership and collaboration policies — ensuring these remain consistent with BioPhorum’s changing environment and drive consistent commercial outcomes
  • Lead on Phorum pricing strategies, providing a clear and easily digestible pricing model that can be used by both the Phorum and Commercial organisations; lead on the annual pricing review process, inputting relevant and robust pricing data that lead to credible recommendations, supported by the organisation, while also developing the necessary support to enable pricing conversations with member organisations
  • Map existing Phorums against the product lifecycle to be clear where each Phorum sits on this lifecycle. Define the product management actions required to protect and grow these Phorums, and especially for emerging Phorums, establish clear plans required to progress the maturity of these Phorums by following BioPhorum’s gated product management process
  • Own the description of BioPhorum’s Phorum collaboration model and the top-level Phorum value proposition, working with the commercial team to ensure that this is represented strongly in our marketing activities
  • Ensure BioPhorum has the commercial tools and collateral to describe the value proposition to the entire organisation (especially the Phorums). Develop and conduct the necessary training so that the proposition is understood, and members and potential members have a clear picture of how an investment in BioPhorum will deliver value to them
  • Assess new Phorum opportunities, including potential market size, target members, pricing, and positioning. Ensure the market for the Phorum exists and can reach maturity in line with its business case by running early collaboration roundtables and developing relationships with key sponsors to develop a clear programme and value proposition based on user and buyer needs
  • Manage the testing, creation, and establishment of new Phorums through the gated Phorum development process, ensuring delivery of the investment case and adherence to the Product organisation’s processes/standards. Build, own, and deliver the handover to the delivery team within a new Phorum, especially the incumbent Phorum Director
  • Through the development of strong relationships with Senior Phorum Directors (SPDs) and Phorum Directors (PDs), build a scalable and repeatable approach/process to identify deliverables or outcomes within the Phorums that could be productised and monetised, including Proof of Concepts, senior-level roundtable events, regional collaboration models, and any other levers to grow the scope of BioPhorum’s collaboration products
  • Define a scalable and credible opportunity assessment methodology that clearly determines the viability of Proof of Concepts (PoCs) emerging from the Phorums, ensuring time and resources are deployed with a high chance of traction
  • Build and run the process for rapid prototyping for PoCs, ensuring strong member engagement, a clear pathway to early monetisation, and the ongoing commercial models are defined and agreed — making sure members fund PoCs and commercial risk is distributed across participating members
  • Evaluate the competitive landscape to identify emerging competitive entrants, ensuring BioPhorum maintains a strong market position with clear benefits versus any competitors entering the market. Work with the External Partners Manager to ensure that partnership opportunities to minimise competitive threats are executed
  • Identify partnership opportunities that can drive ongoing commercial growth, ensuring robust terms of engagement, clear accountabilities for all parties, and expected commercial outcomes
Desired Qualifications
  • Experience working within a private equity environment
  • Practical experience within the Bio-manufacturing, Pharmaceutical or life-sciences industries

BioPhorum is a platform that connects professionals in the biopharmaceutical and medical device industries to enhance collaboration and drive progress. It offers a range of services to its members, including tools for environmental monitoring performance qualification (EMPQ), access to extractables data, and information on host cell proteins. Members, which include pharmaceutical companies, biotech firms, and regulatory bodies, pay membership fees to utilize these resources and gain insights into industry standards and regulatory requirements. What sets BioPhorum apart from its competitors is its focus on creating a collaborative environment where industry players can work together to tackle shared challenges and develop best practices. The main goal of BioPhorum is to help its members navigate regulatory complexities and accelerate the development of sustainable medicines.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

London, United Kingdom

Founded

2008

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Brookwood Global expands training offerings in clinical research and drug safety.
  • Partnership with Scitara enhances digital maturity in biopharma manufacturing.
  • Launch of BioPhorum Sustainability aligns with industry emphasis on sustainable practices.

What critics are saying

  • Rapid tech advancements may outpace BioPhorum's integration capabilities, reducing competitive edge.
  • Integration challenges from Brookwood Global acquisition could disrupt operations and member satisfaction.
  • Reliance on membership fees risks revenue if economic downturns affect member budgets.

What makes BioPhorum unique

  • BioPhorum offers unique collaborative tools for biopharmaceutical and medical device industries.
  • The company provides specialized services like EMPQ and extractables data portals.
  • BioPhorum fosters a trusted environment for regulatory compliance and innovation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Company News

PharmiWeb
May 20th, 2025
Biophorum Announces Appointment Of Dr. Uwe Buecheler To Board Of Directors

19 May 2025London, UKBioPhorum, the global organisation accelerating collaboration between biopharmaceutical and medical device industry leaders, is pleased to announce the appointment of Dr. Uwe Buecheler, as Non-Executive Director (NED) to its Board of Directors, effective May 19, 2025.Dr. Buecheler brings a wealth of experience and expertise in the biopharmaceutical industry, having held various leadership roles in development operations, strategic planning, and innovation. He has overseen more than 30 biologics launches, including several top global biopharmaceuticals and has held senior roles in regulatory affairs, CMC development, biosafety, quality, CDMO business and operations.Dr. Buecheler led the expansion of Boehringer Ingelheim's Global Operations Network in the US and China and pioneered the first Biologics MAH approval in Shanghai. He also contributed to major expansion projects in aseptic processing, microbial manufacturing, and large-scale mammalian cell culture operations

Pharmaceutical Manufacturer
Sep 2nd, 2024
BioPhorum acquires training organisation Brookwood Global

BioPhorum acquires training organisation Brookwood Global.

PharmiWeb
Aug 27th, 2024
Biophorum Acquires Training Organization Brookwood Global

BioPhorum, the global organization accelerating collaboration between biopharmaceutical and medical device industry leaders, has today announced the acquisition of Brookwood Global, a UK-based provider of training and educational content for professionals operating in the field of clinical research.BioPhorum has been at the heart of the biopharmaceutical industry for more than 15 years. Trusted by leaders from across the industry, it enables them to work together in non-competitive, confidential settings to seek out solutions for the benefit of all. Its members are united by their drive to save and improve patient outcomes and they recognize BioPhorum as the engine room for change in their industry.Brookwood Global is a privately owned organization, based in the UK, that has been delivering professional development solutions in the fields of clinical research and drug safety since 1996. Brookwood has trained more than 100,000 clinical research staff from c. 120 countries worldwide.On announcing the acquisition, Deborah Kobewka, BioPhorum CEO, said “We are delighted to be joining forces with the team at Brookwood. Their expertise in digital training integrates perfectly with our advanced knowledge of the biopharmaceutical and life sciences industries, creating opportunities for diversification and growth for both organizations.“The relationship also provides BioPhorum with the opportunity to expand our unique proposition into adjacent and connected segments of the pharmaceutical process/value chain, and to develop new services that will help our members derive maximum value from their relationship with us

Vespa Capital
Nov 21st, 2022
SelectScience partners with BioPhorum to launch Virtual Biopharmaceutical Summit 2022

Vespa Capital portfolio company SelectScience will next week launch the Virtual Biopharmaceutical Summit 2022 in partnership with BioPhorum.

Labiotech
Sep 6th, 2022
Meeting Tech Transfer Challenges When Manufacturing New Biopharmaceuticals

With increasingly complex therapeutics arriving almost monthly, efficient technology transfer between biopharma and manufacturers is more important than ever. Ken Forman, senior director of product strategy at IDBS, explains how good digital strategies can avoid common pitfalls in the tech transfer process. Biopharmaceutical lifecycle management (BPLM) is the key to delivering novel therapies and lifesaving drugs to the world. It encapsulates every stage of drug development, including drug candidate identification, clinical trials establishing efficacy, manufacturing processes and supply chain activities for delivering these therapies to patients